DOCS showing early bounce potential above $19.94 supportCurrent Price: 19.94 (Analysis was generated on Monday Morning)
Direction: LONG
Confidence level: 42%(Limited trader coverage and low tweet volume, but bullish sentiment slightly outweighs bearish sentiment and price is stabilizing near psychological $20 support.)
Targets
Target 1: 20.60
Target 2
Doximity, Inc.
No trades
No trades
Compare with Doximity, Inc.
0.90 USD
196.05 M USD
644.86 M USD
122.76 M
Last report date
Aug 6, 2026
Report period
Q1 2026
EPS
0.29 USD
Revenue
156.62 M USD
Earnings call summary
Q1 FY26 revenue grew 15% year-over-year to $146M, beating guidance, with adjusted EBITDA margin at 55% and free cash flow up 52%. AI product launches and the Pathway acquisition are driving engagement and future growth, while guidance remains cautious due to policy uncertainty.
Company info
Sector
Industry
CEO
Jeffrey A. Tangney
Website
Headquarters
San Francisco
Founded
2010
IPO date
Jun 24, 2021
ISIN
US26622P1075
CUSIP
26622P107
FIGI
BBG0026ZJQX7
Identifiers
ISIN US26622P1075
Doximity, Inc. engages in the development and operation of an online platform for medical professionals. Its cloud-based software has the ability to enable users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. The company was founded by Shari Buck, Konstantin Guericke, Nate Gross, and Jeffrey A. Tangney on April 16, 2010 and is headquartered in San Francisco, CA.
DOCS in BUY ZONEMy trading plan is very simple.
I buy or sell when at either of these events happen:
* Price tags the top or bottom of parallel channel zones
* Money flow volume spikes beyond it's Bollinger Bands
So...
Here's why I'm picking this symbol to do the thing.
Price in buying zone at bottom of channe
DOCS Potential ReversalWatching DOCS finally broke through 61 ish, coming back to fill the gap around 59.50.
Once it gets there and it will. Be waiting on my reversal pattern on lower time frame. Take 1-1 on the lower tfs. See if it breaks above or wants to go lower. Tight SLS until reversal confirmed on the 15. Take you
Bullish opportunity after reaction from 10 and 20 EMAAnother opportunity I'm tracking is with Doximity (DOCS)—a trade I’m already involved in. I’ve been gradually scaling in more capital, as the price action continues to offer favorable entries that align with my strategy.
The stock recently broke out of a long-standing descending channel, and that b
Breaking: Doximity Stock Jumps 37% On Upbeat Annual OutlookDoximity Inc. (NASDAQ: DOCS), the leading digital platform for U.S. medical professionals, has made headlines with its stock skyrocketing 37% following a stellar earnings report and an upbeat annual outlook. The company’s third-quarter fiscal 2025 results not only surpassed analyst expectations but
Doximity Is Preparing To Report Another Strong QuarterKey arguments supporting the idea
• Doximity is a leader in the rapidly growing telemedicine industry.
• The results for Q3 FY2025 may once again impress investors due to the use
of AI tools.
• Maintaining high growth rates of financial indicators and a strong balance
sheet in the medium term.
New Setup: DOCSDOCS : I have a swing trade setup signal. I'm looking to enter long if the stock can manage to CLOSE above the last candle high(BUY). If triggered, I will then place a stop-loss below (SL) and a price target above it(TP-50%,move SL to breakeven), then using the close below the 10SMA as my trailing s
Betting on $DOCS: A Technical Analysis Forecasting 8% GrowthNYSE:DOCS shows strong performance with a Relative Strength (RS) rating of 98. The On-Balance Volume (OBV) has been rising since October 1st, indicating ongoing buying interest. The stock is forming a bullish base along the trend line, supported by the 10-day and 20-day Exponential Moving Averages
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of DOCS is 25.29 USD — it has increased by 1.71% in the past 24 hours. Watch Doximity, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Doximity, Inc. stocks are traded under the ticker DOCS.
DOCS stock has fallen by −2.46% compared to the previous week, the month change is a 13.57% rise, over the last year Doximity, Inc. has showed a −61.37% decrease.
We've gathered analysts' opinions on Doximity, Inc. future price: according to them, DOCS price has a max estimate of 47.00 USD and a min estimate of 18.00 USD. Watch DOCS chart and read a more detailed Doximity, Inc. stock forecast: see what analysts think of Doximity, Inc. and suggest that you do with its stocks.
DOCS reached its all-time high on Sep 10, 2021 with the price of 107.79 USD, and its all-time low was 17.15 USD and was reached on May 14, 2026. View more price dynamics on DOCS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DOCS stock is 2.62% volatile and has beta coefficient of 2.19. Track Doximity, Inc. stock price on the chart and check out the list of the most volatile stocks — is Doximity, Inc. there?
Today Doximity, Inc. has the market capitalization of 4.45 B, it has increased by 4.64% over the last week.
Yes, you can track Doximity, Inc. financials in yearly and quarterly reports right on TradingView.
Doximity, Inc. is going to release the next earnings report on Nov 5, 2026. Keep track of upcoming events with our Earnings Calendar.
DOCS earnings for the last quarter are 0.29 USD per share, whereas the estimation was 0.30 USD resulting in a −4.27% surprise. The estimated earnings for the next quarter are 0.34 USD per share. See more details about Doximity, Inc. earnings.
Doximity, Inc. revenue for the last quarter amounts to 156.62 M USD, despite the estimated figure of 151.77 M USD. In the next quarter, revenue is expected to reach 170.45 M USD.
DOCS net income for the last quarter is 24.32 M USD, while the quarter before that showed 19.11 M USD of net income which accounts for 0.00% change. Track more Doximity, Inc. financial stats to get the full picture.
No, DOCS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 19, 2026, the company has 880 employees. See our rating of the largest employees — is Doximity, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Doximity, Inc. EBITDA is 220.60 M USD, and current EBITDA margin is 36.63%. See more stats in Doximity, Inc. financial statements.
Like other stocks, DOCS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Doximity, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Doximity, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Doximity, Inc. stock shows the sell signal. See more of Doximity, Inc. technicals for a more comprehensive analysis.









